Jonathan Anderman
Vermögen: 109 480 $ am 31.05.2026
Vermögen: 109 480 $ am 31.05.2026
Jonathan E.
Anderman is Secretary, General Counsel & Senior Vice President at Compass Therapeutics, Inc. since 2021.
Formerly, Mr. Anderman was Global Commercial Counsel at Biogen, Inc. from 2020 to 2021 and Assistant General Counsel at Intarcia Therapeutics, Inc. in 2018.
Mr. Anderman completed undergraduate studies at The Pennsylvania State University and graduate studies at Boston University School of Law.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.04.2026 | 46.000 ( 0,03 % ) | 109 480 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | General Counsel | 01.08.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01.08.2021 |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Corporate Officer/Principal | 01.08.2018 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Boston University School of Law
Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compass Therapeutics, Inc.
Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen